StockNews.com Downgrades Ultralife (NASDAQ:ULBI) to Hold

Ultralife (NASDAQ:ULBIGet Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Tuesday.

Ultralife Price Performance

NASDAQ ULBI traded down $0.17 on Tuesday, reaching $5.58. The company’s stock had a trading volume of 48,250 shares, compared to its average volume of 74,128. The firm has a market cap of $92.78 million, a PE ratio of 10.15 and a beta of 1.05. The business has a 50-day moving average price of $7.01 and a 200 day moving average price of $7.94. Ultralife has a 52 week low of $5.31 and a 52 week high of $13.39. The company has a current ratio of 3.30, a quick ratio of 1.62 and a debt-to-equity ratio of 0.04.

Institutional Trading of Ultralife

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. increased its stake in Ultralife by 250.8% in the third quarter. JPMorgan Chase & Co. now owns 47,458 shares of the technology company’s stock valued at $429,000 after acquiring an additional 33,929 shares during the period. Geode Capital Management LLC grew its stake in Ultralife by 1.2% during the third quarter. Geode Capital Management LLC now owns 232,681 shares of the technology company’s stock worth $2,104,000 after buying an additional 2,835 shares during the last quarter. IFP Advisors Inc bought a new stake in Ultralife during the fourth quarter worth about $85,000. Janney Montgomery Scott LLC grew its stake in Ultralife by 0.9% during the fourth quarter. Janney Montgomery Scott LLC now owns 447,000 shares of the technology company’s stock worth $3,330,000 after buying an additional 3,850 shares during the last quarter. Finally, Barclays PLC grew its stake in Ultralife by 21.3% during the third quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock worth $121,000 after buying an additional 2,355 shares during the last quarter. Institutional investors own 30.68% of the company’s stock.

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Featured Articles

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.